Form 8 OPD - Futura Medical PLC

Futura Medical PLC

17 September 2026

 

FORM 8 (OPD)

PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER

Rules 8.1 and 8.2 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Full name of discloser:	Futura Medical plc
(b) Owner or controller of interests and short positions disclosed, if different from 1(a):  The naming of nominee or vehicle companies is insufficient.  For a trust, the trustee(s), settlor and beneficiaries must be named.	N/A
(c) Name of offeror/offeree in relation to whose relevant securities this form relates:  Use a separate form for each offeror/offeree	Futura Medical plc
(d) Is the discloser the offeror or the offeree?	OFFEREE
(e) Date position held:  The latest practicable date prior to the disclosure	16 September 2026
(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?  If it is a cash offer or possible cash offer, state “N/A”	N/A

2. POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates

Class of relevant security:	Ordinary shares of 0.2 pence each
	Interests		Short positions
	Number	%	Number	%
(1) Relevant securities owned and/or controlled:	Nil	0	Nil	0
(2) Cash-settled derivatives:	Nil	0	Nil	0
(3) Stock-settled derivatives (including options) and agreements to purchase/sell:	Nil	0	Nil	0
TOTAL:	Nil	0	Nil	0

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

(b) Rights to subscribe for new securities

Class of relevant security in relation to which subscription right exists:	None
Details, including nature of the rights concerned and relevant percentages:	None

3. POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER MAKING THE DISCLOSURE

Details of any interests, short positions and rights to subscribe (including directors’ and other employee options) of any person acting in concert with the party to the offer making the disclosure:

Interests in Futura Medical plc's ordinary shares in which the directors of Futura Medical plc's are interested: Name Number of ordinary shares held Percentage of total issued share capital (to two decimal places) Alexander Duggan 5,000,000 0.78 Angela Hildreth 642,857 0.10 Kenneth James 799,501 0.13 Andrew Unitt 68,717 0.01 Roy Davis 40,295 0.01        Options and awards held by directors of the Futura Medical plc: Name Share plan No of ordinary shares under options / awards Date of award Exercise price (per share) Vesting date Expiry date Alexander Duggan 26 LTIP 29,056,032 15 January 26 0.2p 15 January 2027* 15 July 2027 Angela Hildreth 26 LTIP 11,622,413 15 January 2026 0.02p 15 January 2027* 15 July 2027 Angela Hildreth LTIP 1 472,340 7 December 22 0.2p 10 January 23 6 December 32 Angela Hildreth LTIP 2 1,267,742 10 October 23 0.2p 10 October 23 30 October 23 Angela Hildreth Tranche 16 200,000 17 September  19 31p 1 October 21 30 September 26 Angela Hildreth Tranche 17 200,000 21 September 20 15.5p 1 October 22 30 September 27 Angela Hildreth Tranche 18 264,000 5 October 21 37.90p 1 October 23 30 September 28 Angela Hildreth Tranche 20 132,000 14 September 22 45p 1 October 25 30 September 30 Angela Hildreth Tranche 21 264,000 6 April 23 43.60p 1 April 26 31 March 33 Angela Hildreth Tranche 22 280,000 19 April 24 35.5p 1 April 27 31 March 34 Ken James 26 LTIP 11,622,413 15 January 2026 0.02p 15 January 2027* 15 July 2027 Ken James LTIP 1 509,225 7 December 22 0.2p 10 January 23 6 December 32 Kenneth James LTIP 2 1,366,728 10 October 23 0.2p 10 October 23 30 October 23 Kenneth James Tranche 16 200,000 17 September 19 31p 1 October 21 30 September 26 Kenneth James Tranche 17 240,000 21 September 20 15.5p 1 October 22 30 September 27 Kenneth James Tranche 18 264,000 5 October 21 37.90p 1 October 23 30 September 28 Kenneth James Tranche 20 132,000 14 September 22 45p 1 October 25 30 September 30 Kenneth James Tranche 21 264,000 6 April 23 43.60p 1 April 26 31 March 33 Kenneth James Tranche 22 280,000 19 April 24 35.5p 1 April 27 31 March 34 Andrew Unitt N/A N/A N/A N/A N/A N/A Roy Davis N/A N/A N/A N/A N/A N/A *The extent to which awards under the 26 LTIP vest is subject to the achievement of performance targets with those options expiring 6 months from that date.         Interests of connected advisers: Name Number of ordinary shares held Percentage of total issued share capital (to two decimal places) Benjamin Turner, James Pope & close relatives** 21,749,999 3.40        Warrants  (exercisable in return for one Ordinary Share each) held over Futura Medical plc's Ordinary Shares ("Warrants") by persons acting in concert (connected adviser) with Futura Medical plc Name Date of grant Expiry date Number of Warrants held Exercise Price per Warrant Turner Pope Investments (TPI) Limited 4 December 2025 4 December 2030 34,375,000 1p

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer making the disclosure or any person acting in concert with it: Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”

None

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer making the disclosure, or any person acting in concert with it, and any other person relating to: (i) the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced: If there are no such agreements, arrangements or understandings, state “none”

None

(c) Attachments

Are any Supplemental Forms attached?

Supplemental Form 8 (Open Positions)	NO
Supplemental Form 8 (SBL)	NO

Date of disclosure:	17 September 2026
Contact name:	Angela Hildreth
Telephone number:	01483 685670

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on [phone].

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

 

END